Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-026-9 | CAS number: 91050-80-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented publication which meets basic scientific principles (lack of details on test material, no ophthalmologic or neurobehavioral examinations).
Data source
Reference
- Reference Type:
- publication
- Title:
- Subacute Oral Toxicity of Polyglaycerol Ester
- Author:
- King, W.R., Michael, W.R., Coots, R.H.
- Year:
- 1 971
- Bibliographic source:
- Toxicology and Applied Pharmacology, 20, 327-333
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- lack of details on test material, no ophthalmologic or neurobehavioral examinations
- GLP compliance:
- no
Test material
- Reference substance name:
- deca-glycerol deca-oleate
- IUPAC Name:
- deca-glycerol deca-oleate
- Details on test material:
- - Name of test material (as cited in study report): decaglycerol deca-oleate
- Analytical purity: no data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: mean body weight - 72 g (males), 69 g (females)
- Housing: in individual cages
- Diet: basal diet consisting of ground pellets (Purina Lab Chow), inorganic salts, vitamins, casein and fat, ad libitum, except during periods of urine collection
- Water: ad libitum, except during periods of urine collection
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS: for exact composition of dosing solutions see Table 1 under "Any other information on materials and methods including tables"
- Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- daily, 7days/week (except during urine collection)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2.5 % (Diet No.1), 5 % (Diet No.2), 10 % (Diet No.3)
Basis:
nominal in diet
- No. of animals per sex per dose:
- 10 males and females
- Control animals:
- other: Diet No.4: free oleic acid + glycerol corresponding to total fatty acid and glycerol content of Diet No.2 (to determine if free fatty acids and glycer... (see attached file)
- Details on study design:
- - Dose selection rationale: substance is used as a food additive and is therefore tested at the specified dose levels
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: regular observations were done
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: regular observations were done
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes
HAEMATOLOGY: Yes
- Time schedule for collection of blood: during fifth and eleventh week and from severed neck vessels at necropsy
- Anaesthetic used for blood collection: No data
- Animals fasted: No
- How many animals: all animals
- Parameters checked in table [No.6] were examined.
URINALYSIS: Yes
- Time schedule for collection of urine: during third and ninth week of the study
- Metabolism cages used for collection of urine: No data
- Animals fasted: Yes
- Parameters examined: total nitrogen, specific gravity and pH
NEUROBEHAVIOURAL EXAMINATION: Yes
- Dose groups that were examined: regular observations of behavior of animals was done
OTHER:
- collection of feces during fourth and tenth week for determination of total fatty acid (TFA) absorption - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (see Table 2)
HISTOPATHOLOGY: Yes (see Table 2) - Statistics:
- Statistic testing for significance compared to soybean control groups was done but method used is not specified.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- higher nitrogen excretion in females fed 10 % PGE but no changes during the histologic examination of the urinary tract were found
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY
Throughout the study all animals appeared to be in excellent health
BODY WEIGHT GAIN/FOOD CONSUMPTION AND FOOD EFFICIENCY
Males fed PGE at the high dietary level (10 %) consumed more food and had a poorer feed efficiency value than did male control animals, however despite decreased feed efficiency those animals consumed enough food to maintain normal growth.
HAEMATOLOGY/CLINICAL CHEMISTRY
Values fell within normal ranges, and there were no indications of any blood disorder. Some values were significantly different from SBO controls, however differences were usually quite small and in no case established any trend or pattern indicative of a dose-related effect.
URINALYSIS
Urine collected from each animal appeared to be normal in regard to color clarity, sediment, specific gravity and pH, total nitrogen excretion during the third and ninth week by females fed PGE at the 10 % level was significantly greater than the control value and appears to be related to dietary treatment, the highest nitrogen excretion (male and female) was from the animals fed the highest dose PGE, the reason for this difference is not understood but it should be recognized that other parameters, including three derived from histologic examination of the urinary tract were normal
ORGAN WEIGHTS
There were no statistical differences for all organs examined.
GROSS PATHOLOGY
The only gross observation of significance was what appeared to be very mild, chronic murine pneumonia in 18% of the animals, but the affected animals were scattered throughout all the groups and the effect was not related to the feeding of PGE.
HISTOPATHOLOGY: NON-NEOPLASTIC
Microscopic examination confirmed the pneumonitis but did not reveal any other changes as evidence of toxicity
OTHER FINDINGS
The percentage of dietary fatty acids absorbed decreased as the level of PGE in the diet was increased. In all cases fat absorption by animals fed PGE at the 5 and 10 % dietary levels was significantly less than corresponding SBO control values. Absorption in animals fed the lowest dose was also less but not significantly different. Values from the group fed oleic acid and glycerol fell between those of the 5 % PGE and SBO control.
Gas-liquid Chromatography analyses of faecal fatty acids showed that excretion of oleic acid increased in a dose-related fashion: the oleic acid content of faecal fatty acids from animals fed the SBO control diet was 23 % compared to 32, 41 and 51 % when PGE was fed at levels of 2.5, 5, and 10 %. The increased excretion of fatty acids in general and oleic acid in particular shows that absorption of dietary PGE was not complete. The faecal oleic acid may have resulted from the excretion of intact PGE or from hydrolyzed or partially hydrolyzed but unabsorbed material. The oleic acid content of faecal fatty acids from animals fed free oleic and glycerol was 41 % corresponding exactly to the 5 % PGE group.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 10 other: %
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: decreased total fat absorption
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table3: Food Consumption, Body Weight Gain and Feed Efficiency
Cumulative Food consumption (g) | Cumulative gain in body weight (g) | Cumulative feed efficieniesa | ||||
Dietary Group | Male | Female | Male | Female | Male | Female |
2.5 % PGE | 1585 | 1262 | 393 | 195 | 24.8 | 15.6 |
5 % PGE | 1589 | 1365 | 384 | 191 | 24.2 | 14.4 |
10 % PGE | 1753 | 1293 | 397 | 205 | 22.9b | 15.9 |
Free Acid | 1527 | 1140 | 382 | 191 | 25.0 | 16.8 |
Soybean Oil control (SBO) | 1615 | 1237 | 404 | 193 | 25.0 | 15.8 |
a - Weigth gained g/100g diet consumed
b - Significantly different from the SBO control (P < 0.05)
Table4: Urine data from the 90 -day Feeding study
Total Nitrogen Excretiona |
||||
Third week | Ninth week | |||
Dietary Group | Males | Females | Males | Females |
2.5 % PGE | 97.3 | 93.6 | 145.4 | 131.8 |
5 % PGE | 94.1 | 93.0 | 142.0 | 106.2 |
10 % PGE | 115.3 | 114.8b | 169.6 | 138.7b |
Free Acid | 99.9 | 95.4 | 143.0 | 120.8 |
Soybean Oil Control (SBO) | 106.3 | 91.0 | 143.7 | 104.6 |
a - Nitrogen (mg) excreted during the 16 hour collection period
b - Significantly different from the SBO control (P < 0.05)
Table5: Total Fatty Acid (TFA) Absorption data
TFA absorption (% of fed) |
||||
Fourth week | Tenth week | |||
Dietary Group | Males | Females | Males | Females |
2.5 % PGE | 88.3 | 90.5a | 90.1a | 91.8a |
5 % PGE | 83.6a | 86.7a | 85.2a | 89.5a |
10 % PGE | 73.1a | 73.8a | 70.1a | 68.8a |
Free Acid | 87.0a | 89.5a | 88.8a | 91.5 |
Soybean Oil Control (SBO) | 89.3 | 92.9 | 91.9 | 93.9 |
a - Significant different from the SBO control (P<0.05)
Table6: Blood values from the 90 -day feeding study
Dietary group | Hemoglobina | Hematocritb | RBC countc | WBC countd | Lymphocytese | Neutrophilse | Monocytese | Eosinophilse |
Males | ||||||||
2.5 % PGE | 15.7 | 47 | 8.18 | 6700 | 92 | 6 | 1 | 1 |
5 % PGE | 15.7 | 48 | 8.36 | 7700 | 91 | 7 | 1 | 1 |
10 % PGE | 15.9 | 48 | 8.66 | 8750 | 94 | 4 | 1 | 1 |
Free Acid | 16.1 | 48 | 8.32 | 7250 | 0 | 8 | 1 | 1 |
Soybean Oil control (SBO) | 15.5 | 47 | 8.48 | 8250 | 91 | 7 | 1 | 1 |
Females |
||||||||
2.5 % PGE | 15.2 | 46 | 8.47* | 4500 | 91 | 6 | 2 | 1 |
5 % PGE | 16.0 | 47 | 8.04* | 5625 | 93 | 6 | 1 | 0* |
10 % PGE | 15.3 | 46 | 7.06 | 4675 | 92 | 7 | 1 | 0* |
Free Acid | 16.1 | 48 | 7.70 | 5925 | 94 | 5 | 1 | 0* |
Soybean Oil control (SBO) | 15.9 | 46 | 7.34 | 5575 | 95 | 3 | 1 | 1 |
a - g/100mL
b - Packed Cell Volume (%)
c - RBC = Millions of red blood cells per cubic millimeter of blood
d - WBC = Number of white blood cells per cubic millimeter of blood
e - Differential count of white blood cells, expressed as a percentage of total white cells
*Significantly different from the SBO control (P<0.05)
Applicant's summary and conclusion
- Conclusions:
- All animals fed PGE appeared to be in excellent health throughout the study and no adverse effects were found upon survival, growth, organ weights, organ, body weight ratios and hematological values. There were no significant gross or microscopic tissue changes which would be attributed to dietary treatment. Total fat absorption decreased in a dose-related response, showing that absorption of PGE was not complete. Additionally, excretion of nitrogen in the urine by females fed 10 % PGE was significantly greater than the control but this difference is not understood.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.